Altria Group Inc.

NYSE:MO  
43.41
+0.90 (+2.12%)
4:26:16 PM EDT: $43.67 +0.26 (+0.60%)
Products

FDA Denies Authorization To Market JUUL Products

Published: 06/23/2022 14:44 GMT
Altria Group Inc. (MO) - :fda Denies Authorization to Market Juul Products.
FDA - Issued Marketing Denial Orders (mdos) to Juul Labs Inc. for All of Their Products Currently Marketed in the United States.
FDA - to Date, the FDA Has Not Received Clinical Information to Suggest an Immediate Hazard Associated With the Use of the Juul Device Or Juulpods.
FDA - FDA Recommends Against Modifying Or Adding Substances to Tobacco Products.
FDA - All New Tobacco Products on Market Without Statutorily Required Premarket Authorization Are Marketed Unlawfully & Subject to Enforcement Action.
FDA - in Addition to Ensuring Juul Complies With This Order, FDA Intends to Ensure Compliance by Distributors and Retailers.
FDA - Continues to Work to Complete Its Review of the Remaining Pending Applications for Deemed Products Submitted by the Sept.
9, 2020, Deadline.
Further Company Coverage: Mon ((reuters.
Briefs@thomsonreuters.
Com;)).